Assembly Bio to launch four infectious disease trials in 2024
Assembly Bio has four candidates in its pipeline, one of which is being developed as part of a partnership with Gilead Sciences.
Assembly Bio has four candidates in its pipeline, one of which is being developed as part of a partnership with Gilead Sciences.
Originally operating as a subsidiary under BeiGene, Pi Health has become an independent company with a Series A raise.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of new treatment...
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Psychedelic treatments for mental health: Is there substance behind the hype?
AstraZeneca’s Evusheld fails to improve Covid outcomes in Phase III trial
Osivax kicks off broad spectrum coronavirus vaccine trial
SCOPE: FDA facilitates AI and ML use for clinical trials and drug development